» Articles » PMID: 20543887

Thromboxane and the Thromboxane Receptor in Cardiovascular Disease

Overview
Journal Clin Lipidol
Date 2010 Jun 15
PMID 20543887
Citations 54
Authors
Affiliations
Soon will be listed here.
Abstract

Thromboxane A(2) (TXA(2)), the primary product of COX-1-dependent metabolism of arachidonic acid, mediates its biological actions through the TXA(2) receptor, termed the TP. Irreversible inhibition of platelet COX-1-derived TXA(2) with low-dose aspirin affords protection against primary and secondary vascular thrombotic events, underscoring the central role of TXA(2) as a platelet agonist in cardiovascular disease. The limitations associated with aspirin use include significant gastrointestinal toxicity, bleeding complications, potential interindividual response variability and poor efficacy in some disease states. This, together with the broad role of TXA(2) in cardiovascular disease beyond the platelet, has refocused interest towards additional TXA(2)-associated drug targets, in particular TXA(2) synthase and the TP. The superiority of these agents over low-dose aspirin, in terms of clinical efficacy, tolerability and commercial viability, remain open questions that are the focus of ongoing research.

Citing Articles

Association of Anabolic Steroid Use With Hypertension and Cardiomyopathy: A Case Study.

Neupane S, Kalra F Cureus. 2024; 16(10):e71775.

PMID: 39559620 PMC: 11570439. DOI: 10.7759/cureus.71775.


Phospholipids, Sphingolipids, and Cholesterol-Derived Lipid Mediators and Their Role in Neurological Disorders.

Farooqui A, Farooqui T Int J Mol Sci. 2024; 25(19).

PMID: 39409002 PMC: 11476704. DOI: 10.3390/ijms251910672.


Targeting Rap1b signaling cascades with CDNF: Mitigating platelet activation, plasma oxylipins and reperfusion injury in stroke.

Wu J, Lohelaid H, Shih C, Liew H, Wang V, Hu W Mol Ther. 2024; 32(11):4021-4044.

PMID: 39256999 PMC: 11573613. DOI: 10.1016/j.ymthe.2024.09.005.


The human gut microbiome and aging.

Bradley E, Haran J Gut Microbes. 2024; 16(1):2359677.

PMID: 38831607 PMC: 11152108. DOI: 10.1080/19490976.2024.2359677.


Doxorubicin alters G-protein coupled receptor-mediated vasocontraction in rat coronary arteries.

Lozahic C, Maddock H, Wheatley M, Sandhu H Naunyn Schmiedebergs Arch Pharmacol. 2024; 397(8):5831-5845.

PMID: 38326659 DOI: 10.1007/s00210-024-02988-x.


References
1.
Parent J, Labrecque P, Driss Rochdi M, Benovic J . Role of the differentially spliced carboxyl terminus in thromboxane A2 receptor trafficking: identification of a distinct motif for tonic internalization. J Biol Chem. 2000; 276(10):7079-85. DOI: 10.1074/jbc.M009375200. View

2.
Daniel T, Liu H, Morrow J, Crews B, Marnett L . Thromboxane A2 is a mediator of cyclooxygenase-2-dependent endothelial migration and angiogenesis. Cancer Res. 1999; 59(18):4574-7. View

3.
McAdam B, Mardini I, Habib A, Burke A, Lawson J, Kapoor S . Effect of regulated expression of human cyclooxygenase isoforms on eicosanoid and isoeicosanoid production in inflammation. J Clin Invest. 2000; 105(10):1473-82. PMC: 315469. DOI: 10.1172/JCI9523. View

4.
Grosser T, Yusuff S, Cheskis E, Pack M, FitzGerald G . Developmental expression of functional cyclooxygenases in zebrafish. Proc Natl Acad Sci U S A. 2002; 99(12):8418-23. PMC: 123082. DOI: 10.1073/pnas.112217799. View

5.
Coyle A, Kinsella B . Characterization of promoter 3 of the human thromboxane A receptor gene. A functional AP-1 and octamer motif are required for basal promoter activity. FEBS J. 2005; 272(4):1036-53. DOI: 10.1111/j.1742-4658.2004.04538.x. View